Vascular density and inflammatory infiltrate in primary oral squamous cell carcinoma and after allogeneic hematopoietic stem cell transplantation
Hematopoietic stem cell transplantation (HSCT) recipients have been reported to have an increased risk of chronic graft versus host disease (cGVHD) and hematological and solid cancers. Oral manifestations are the first signs of cGVHD observed in the majority of patients, and oropharyngeal cancer is the most frequent secondary malignancy occurred after HSCT. In this study, we have evaluated the inflammatory infiltrate cell content and correlated with the vascular density in patients affected by primary oral squamous cell carcinoma (OSCC) from previous healthy controls and OSCC after cGVHD. Results have demonstrated that patients with OSCC after GVHD show a more consistent inflammatory infiltrate as compared with the OSCC ones. In detail, the inflammatory background composed of CD3-positive T cells, tryptase-positive mast cells, CD31-positive endothelial cells, and CD68-positive macrophages may be more pronounced in the setting of GVHD + OSCC than in the control group. By contrast, CD20-positive B cells and CD1a-positive dendritic cells were more abundant in the latter population. Finally, a positive correlation was found as between vascular density and inflammatory cell infiltration in both GVHD + OSCC and OSCC groups. Overall, these results confirm the role played by immune cells in enhancing tumor progression and angiogenesis and suggest a potential therapeutic strategy involving inhibition of recruitment of immune cells to the tumor microenvironment and blockade of pro-tumoral effects and pro-angiogenic functions.
KeywordsAllogeneic hematopoietic stem cell transplantation Chronic graft versus host disease Inflammatory infiltrate Primary oral squamous cell carcinoma Vascular density
All authors have seen and approved the manuscript being submitted.
This work was supported in part by Fellowship FIRC-AIRC 1-year fellowship “Laura Bassi” id. 20879 to TA.
Compliance with ethical standards
Full ethical approval and signed informed consent from individual patients were obtained to conduct the study. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions.
Conflict of interest
The authors declare that they have no conflict of interest.
- 3.Dander E, Balduzzi A, Zappa G, Lucchini G, Perseghin P, Andre V et al (2009) Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation. Transplantation 88(11):1261–1272. https://doi.org/10.1097/TP.0b013e3181bc267e CrossRefPubMedGoogle Scholar
- 5.Majhail NS, Brazauskas R, Rizzo JD, Sobecks RM, Wang Z, Horowitz MM, Bolwell B, Wingard JR, Socie G (2011) Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning. Blood 117(1):316–322. https://doi.org/10.1182/blood-2010-07-294629 CrossRefPubMedCentralPubMedGoogle Scholar
- 6.Inamoto Y, Shah NN, Savani BN, Shaw BE, Abraham AA, Ahmed IA, Akpek G, Atsuta Y, Baker KS, Basak GW, Bitan M, DeFilipp Z, Gregory TK, Greinix HT, Hamadani M, Hamilton BK, Hayashi RJ, Jacobsohn DA, Kamble RT, Kasow KA, Khera N, Lazarus HM, Malone AK, Lupo-Stanghellini MT, Margossian SP, Muffly LS, Norkin M, Ramanathan M, Salooja N, Schoemans H, Wingard JR, Wirk B, Wood WA, Yong A, Duncan CN, Flowers MED, Majhail NS (2015) Secondary solid cancer screening following hematopoietic cell transplantation. Bone Marrow Transplant 50(8):1013–1023. https://doi.org/10.1038/bmt.2015.63 CrossRefPubMedCentralPubMedGoogle Scholar
- 7.Atsuta Y, Suzuki R, Yamashita T, Fukuda T, Miyamura K, Taniguchi S, Iida H, Uchida T, Ikegame K, Takahashi S, Kato K, Kawa K, Nagamura-Inoue T, Morishima Y, Sakamaki H, Kodera Y, Japan Society for Hematopoietic Cell Transplantation (2014) Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease. Ann Oncol 25(2):435–441. https://doi.org/10.1093/annonc/mdt558 CrossRefPubMedGoogle Scholar
- 8.Demarosi F, Lodi G, Carrassi A, Soligo D, Sardella A (2005) Oral malignancies following HSCT: graft versus host disease and other risk factors. Oral Oncol 41(9):865–877. https://doi.org/10.1016/j.oraloncology.2005.02.001 CrossRefPubMedGoogle Scholar
- 12.Rizzo JD, Curtis RE, Socie G, Sobocinski KA, Gilbert E, Landgren O, Travis LB, Travis WD, Flowers MED, Friedman DL, Horowitz MM, Wingard JR, Deeg HJ (2009) Solid cancers after allogeneic hematopoietic cell transplantation. Blood 113(5):1175–1183. https://doi.org/10.1182/blood-2008-05-158782 CrossRefPubMedCentralPubMedGoogle Scholar
- 14.Imanguli MM, Pavletic SZ, Guadagnini JP, Brahim JS, Atkinson JC (2006) Early and late features of chronic graft-versus-host disease of oral mucosa: review of available therapies. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101(2):175–183. https://doi.org/10.1016/j.tripleo.2005.08.028 CrossRefPubMedGoogle Scholar
- 21.Tamma R, Guidolin D, Annese T, Tortorella C, Ruggieri S, Rega S, Zito FA, Nico B, Ribatti D (2017) Spatial distribution of mast cells and macrophages around tumor glands in human breast ductal carcinoma. Exp Cell Res 359(1):179–184. https://doi.org/10.1016/j.yexcr.2017.07.033 CrossRefPubMedGoogle Scholar
- 25.Ringden O, Brazauskas R, Wang Z, Ahmed I, Atsuta Y, Buchbinder D et al (2014) Second solid cancers after allogeneic hematopoietic cell transplantation using reduced-intensity conditioning. Biol Blood Marrow Transplant 20(11):1777–1784. https://doi.org/10.1016/j.bbmt.2014.07.009 CrossRefPubMedCentralPubMedGoogle Scholar
- 26.Sloand EM, Pfannes L, Ling C, Feng X, Jasek M, Calado R, Tucker ZCG, Hematti P, Maciejewski J, Dunbar C, Barrett J, Young N (2010) Graft-versus-host disease: role of inflammation in the development of chromosomal abnormalities of keratinocytes. Biol Blood Marrow Transplant 16(12):1665–1673. https://doi.org/10.1016/j.bbmt.2010.07.014 CrossRefPubMedCentralPubMedGoogle Scholar
- 32.Ribatti D, Vacca A (2008) Overview of angiogenesis during tumor growth. In: Figg WD, Folkman J (eds) Angiogenesis. Springer, BostonGoogle Scholar
- 37.Carvalho MI, Pires I, Dias M, Prada J, Gregorio H, Lobo L et al (2015) Intratumoral CD3+ T-lymphocytes immunoexpression and its association with c-Kit, angiogenesis, and overall survival in malignant canine mammary tumors. Anal Cell Pathol (Amst) 2015:920409. https://doi.org/10.1155/2015/920409 CrossRefGoogle Scholar
- 42.Lee HS, Myers A, Kim J (2009) Vascular endothelial growth factor drives autocrine epithelial cell proliferation and survival in chronic rhinosinusitis with nasal polyposis. Am J Respir Crit Care Med 180(11):1056–1067. https://doi.org/10.1164/rccm.200905-0740OC CrossRefPubMedCentralPubMedGoogle Scholar